InsidersTradesSigma
Track the 경보제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 경보제약 has recorded 28 reports. Market capitalisation: €124.3bn. The latest transaction was disclosed on 19 March 2026 (Purchase). Among the most active insiders: 종근당홀딩스. All data is accessible without an account.
28
Insider Decl.
n/a
Thresholds
€6,454
22 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,189 of 29,064 companies
28.2
score / 100
Value26
Quality30
FCF yld-27%
Earn yld0.1%
EV/EBITDA14.0x
ROE0.2%
Gross mgn39%
Net mgn0.1%
Debt/EBITDA7.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 March 2026
Declarations28 total
25 of 28 declarations
关于 경보제약
경보제약 是一家在韩国交易所 (XKRX) 上市的医疗保健和制药公司。它专注于创新药物的研发。